ClearBridge Investments’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,436,925
| Closed | -$55.7M | – | 841 |
|
|
2021
Q1 | $55.7M | Sell |
3,436,925
-17,281
| -0.5% | -$280K | 0.04% | 335 |
|
|
2020
Q4 | $73.1M | Buy |
3,454,206
+18,181
| +0.5% | +$385K | 0.06% | 263 |
|
|
2020
Q3 | $50.9M | Sell |
3,436,025
-2,587
| -0.1% | -$38.3K | 0.04% | 286 |
|
|
2020
Q2 | $50.6M | Buy |
3,438,612
+12,532
| +0.4% | +$184K | 0.05% | 269 |
|
|
2020
Q1 | $40.2M | Sell |
3,426,080
-23,364
| -0.7% | -$274K | 0.04% | 273 |
|
|
2019
Q4 | $79.9M | Sell |
3,449,444
-794
| -0% | -$18.4K | 0.07% | 233 |
|
|
2019
Q3 | $63.8M | Buy |
3,450,238
+739,663
| +27% | +$13.7M | 0.06% | 272 |
|
|
2019
Q2 | $50.4M | Buy |
2,710,575
+529,998
| +24% | +$9.85M | 0.04% | 317 |
|
|
2019
Q1 | $53.3M | Buy |
2,180,577
+1,320,025
| +153% | +$32.3M | 0.05% | 300 |
|
|
2018
Q4 | $22.3M | Buy |
+860,552
| New | +$22.3M | 0.02% | 409 |
|